{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:17:48Z","timestamp":1783466268741,"version":"3.55.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Public Research Institute IDIPHISA"},{"name":"RICORS","award":["RD21\/0005\/0010"],"award-info":[{"award-number":["RD21\/0005\/0010"]}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Post-transplant anemia is a prevalent yet often overlooked condition that poses significant risks. Current guidelines consider the same treatment recommendations and goals for these patients as for chronic kidney disease patients not on dialysis. Previous reports demonstrated a lack of awareness and suboptimal management, indicating a pressing need for improvement. We therefore wanted to update the information on post-transplant anemia. We aimed to describe the present state of anemia management, goals and adherence to guidelines within a representative sample of the kidney transplant (KTx) population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We designed a retrospective nationwide multicenter study including outpatients from eight KTx hospitals. Nephrologists gathered data from electronic medical records encompassing demographics, comorbidities, KTx characteristics and immunosuppressive therapy, and information pertaining to anemia management (laboratory values, previously prescribed treatments and subsequent adjustments). The European statement on the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines was the reference for definitions, drug prescriptions and targets. Anemia occurring within the initial 6 months post-transplantation was classified as early onset.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We included 297 patients with post-transplant anemia aged 62.8 years (standard deviation 13.6), 60% of whom were male. They had received a graft from cardiac death or brain death donors (61.6% and 31.1%, respectively) a median of 2.5 years (0.5\u20138.7) before. Among them 77% (n\u00a0=\u00a0228) were classified as having late post-transplant anemia, characterized by a higher prevalence of microcytic and iron deficiency anemia. A total of 158 patients were on erythropoietic-stimulating agents (ESAs) treatment, yet surprisingly 110 of them lacked iron supplementation. Notably, 44 patients had an indication for iron supplementation and among them, 30 exhibited absolute iron deficiency. Out of the 158 patients receiving ESAs, only 39 surpassed the limit for the ESA resistance index, indicating poor response. This resistance was more frequent among patients with early post-transplant anemia (26.1% vs 9.2%). We have identified iron profile, early post-transplant anemia and estimated glomerular filtration rate as factors associated with the highest risk of resistance<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We found that hemoglobin targets are individualized upwards in post-transplant anemia. In this setting, iron therapy continues to be underutilized, especially intravenous, and iron deficiency and prior events (blood transfusion or hospital admission) explain most of the hyporesponsiveness to ESA. This highlights missed opportunities for precise prescription targeting and adherence to established guidelines, suggesting a need for improved management strategies in post-transplant anemia patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfae269","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T09:48:57Z","timestamp":1725097737000},"source":"Crossref","is-referenced-by-count":6,"title":["Post-transplant renal anemia: a call to action from a national study in routine clinical practice"],"prefix":"10.1093","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2114-1385","authenticated-orcid":false,"given":"Jose","family":"Portoles","sequence":"first","affiliation":[{"name":"Nephrology Department, Hospital Universitario Puerta de Hierro, IDIPHISA , Madrid ,","place":["Spain"]},{"name":"Medicine Department, Facultad de Medicina, Universidad Aut\u00f3noma de Madrid, IDIPHISA , Madrid ,","place":["Spain"]},{"name":"Anemia Working Group of the Spanish Society of Nephrology , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1852-2259","authenticated-orcid":false,"given":"Marta","family":"Crespo","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital del Mar , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Mart\u00ednez Belotto","sequence":"additional","affiliation":[{"name":"Nephrology Department, HU Marques de Valdecilla\/IDIVAL , Santander ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Mart\u00ednez Morales","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Universitario Puerta de Hierro, IDIPHISA , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Calatayud Aristoy","sequence":"additional","affiliation":[{"name":"Nephrology Department, HU Dr Peset , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Mora Lopez","sequence":"additional","affiliation":[{"name":"Nephrology Department, HU Miguel Servet, Institute for Health Research Arag\u00f3n (IIS Arag\u00f3n) , Zaragoza ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sthefanny Carolina Gonz\u00e1lez","family":"Garcia","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital del Mar , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5317-7304","authenticated-orcid":false,"given":"Laia","family":"Oliveras","sequence":"additional","affiliation":[{"name":"Nephrology Department, H Bellvitge , Hospitalet de Llobregat ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Colina","sequence":"additional","affiliation":[{"name":"Nephrology Department, HU 12 de Octubre , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3217-8317","authenticated-orcid":false,"given":"Arhsdeep","family":"Singh","sequence":"additional","affiliation":[{"name":"Nephrology Department, HU Puerta del Mar , C\u00e1diz ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4170-9003","authenticated-orcid":false,"given":"Asunci\u00f3n","family":"Sancho Calabuig","sequence":"additional","affiliation":[{"name":"Nephrology Department, HU Dr Peset , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2845-5272","authenticated-orcid":false,"given":"Emilio","family":"Rodrigo Calabia","sequence":"additional","affiliation":[{"name":"Nephrology Department, HU Marques de Valdecilla\/IDIVAL , Santander ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5123-4603","authenticated-orcid":false,"given":"Nuria","family":"Montero","sequence":"additional","affiliation":[{"name":"Nephrology Department, H Bellvitge , Hospitalet de Llobregat ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-7779","authenticated-orcid":false,"given":"Alex","family":"Gutierrez-Dalmau","sequence":"additional","affiliation":[{"name":"Nephrology Department, HU Miguel Servet, Institute for Health Research Arag\u00f3n (IIS Arag\u00f3n) , Zaragoza ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5860-2309","authenticated-orcid":false,"given":"Auxiliadora","family":"Mazuecos","sequence":"additional","affiliation":[{"name":"Nephrology Department, HU Puerta del Mar , C\u00e1diz ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4735-7838","authenticated-orcid":false,"given":"Julio","family":"Pascual","sequence":"additional","affiliation":[{"name":"Nephrology Department, HU 12 de Octubre , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"2024100410264912500_bib1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1056\/NEJM198907203210304","article-title":"Serum erythropoietin levels after renal transplantation","volume":"321","author":"Sun","year":"1989","journal-title":"N Engl J Med"},{"key":"2024100410264912500_bib2","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.2215\/CJN.03290807","article-title":"Pottransplantation anemia: management and rationale","volume":"3","author":"Winkelmayer","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024100410264912500_bib3","article-title":"Report of a WHO scientific group [Internet]","author":"Nutritional anemias","year":"1967"},{"key":"2024100410264912500_bib4","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gft033","article-title":"Kidney Disease: Improving Global Outcomes guidelines on anemia management in chronic kidney disease: a European Renal Best Practice position statement","volume":"28","author":"Locatelli","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2024100410264912500_bib5","doi-asserted-by":"publisher","first-page":"c69","DOI":"10.1159\/000093992","article-title":"Anemia after renal transplantation\u2014role of immunosuppressive drugs and a pathophysiological appraisal","volume":"104","author":"Goldsmith","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"2024100410264912500_bib6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2021.642296","article-title":"Anemia in chronic kidney disease: from pathophysiology and current treatments, to future agents","volume":"8","author":"Portol\u00e9s","year":"2021","journal-title":"Front Med"},{"key":"2024100410264912500_bib7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1034\/j.1600-6143.2002.20506.x","article-title":"Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem?","volume":"2","author":"Yorgin","year":"2002","journal-title":"Am J Transplant"},{"key":"2024100410264912500_bib8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1600-6143.2006.01248.x","article-title":"Kidney disease after heart and lung transplantation","volume":"6","author":"Bloom","year":"2006","journal-title":"Am J Transplant"},{"key":"2024100410264912500_bib9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2215\/CJN.01371005","article-title":"Medical care of kidney transplant recipients after the first posttransplant year","volume":"1","author":"Djamali","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024100410264912500_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/7692376","article-title":"The impact of CKD anemia on patients: incidence, risk factors, and clinical outcomes-a systematic literature review","volume":"2020","author":"Palaka","year":"2020","journal-title":"Int J Nephrol"},{"key":"2024100410264912500_bib11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/15269248221145046","article-title":"A systematic review and meta-analysis of posttransplant anemia with overall mortality and cardiovascular outcomes among kidney transplant recipients","volume":"33","author":"Mekraksakit","year":"2023","journal-title":"Prog Transpl"},{"key":"2024100410264912500_bib12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/ndt\/gfg458","article-title":"Anemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"2024100410264912500_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ckj\/sfz091","article-title":"Anemia and iron deficiency among chronic kidney disease Stages 3-5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated","volume":"13","author":"Wong","year":"2020","journal-title":"Clin Kidney J"},{"key":"2024100410264912500_bib14","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1034\/j.1600-6143.2003.00133.x","article-title":"Prevalence and management of anemia in renal transplant recipients: a European survey","volume":"3","author":"Vanrenterghem","year":"2003","journal-title":"Am J Transplant"},{"key":"2024100410264912500_bib15","doi-asserted-by":"publisher","first-page":"c127","DOI":"10.1159\/000319660","article-title":"Prevalence and management of anemia in renal transplant recipients: data from ten European centres","volume":"117","author":"Molnar","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"2024100410264912500_bib16","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"2024100410264912500_bib17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000516901","article-title":"Managing anemia across the stages of kidney disease in those hyporesponsive to erythropoiesis-stimulating agents","volume":"52","author":"Weir","year":"2021","journal-title":"Am J Nephrol"},{"key":"2024100410264912500_bib18","first-page":"279","article-title":"Kidney disease: improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease","volume":"2","author":"McMurray","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"2024100410264912500_bib19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/ckj\/sfaa054","article-title":"Contemporary management of anemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis","volume":"13","author":"Evans","year":"2020","journal-title":"Clin Kidney J"},{"key":"2024100410264912500_bib20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1681\/ASN.2011060546","article-title":"Correction of postkidney transplant anemia reduces progression of allograft nephropathy","volume":"23","author":"Choukroun","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2024100410264912500_bib21","doi-asserted-by":"publisher","first-page":"b4018","DOI":"10.1136\/bmj.b4018","article-title":"Mortality in renal transplant recipients given erythropoietins to increase hemoglobin concentration: cohort study","volume":"339","author":"Heinze","year":"2009","journal-title":"BMJ"},{"key":"2024100410264912500_bib22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12882-020-01912-8","article-title":"Physical health-related quality of life at higher achieved hemoglobin levels among chronic kidney disease patients: a systematic review and meta-analysis","volume":"21","author":"Guedes","year":"2020","journal-title":"BMC Nephrol"},{"key":"2024100410264912500_bib23","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/ndt\/gfn601","article-title":"Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease","volume":"24","author":"Vaziri","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2024100410264912500_bib24","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"2024100410264912500_bib25","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Drueke","year":"2006","journal-title":"N Engl J Med"},{"key":"2024100410264912500_bib26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1159\/000351175","article-title":"Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease","volume":"37","author":"McCullough","year":"2013","journal-title":"Am J Nephrol"},{"key":"2024100410264912500_bib27","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1053\/j.ajkd.2008.05.029","article-title":"Erythropoietin, iron depletion and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis","volume":"52","author":"Streja","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"2024100410264912500_bib28","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ki.2014.179","article-title":"ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target","volume":"86","author":"Hung","year":"2014","journal-title":"Kidney Int"},{"key":"2024100410264912500_bib29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.kint.2016.03.036","article-title":"An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients","volume":"90","author":"Barbieri","year":"2016","journal-title":"Kidney Int"},{"key":"2024100410264912500_bib30","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1038\/ki.2008.523","article-title":"Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality","volume":"74","author":"L\u00f3pez-G\u00f3mez","year":"2008","journal-title":"Kidney Int"},{"key":"2024100410264912500_bib31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.xkme.2020.06.008","article-title":"Clinical and economic outcomes of erythropoiesis-stimulating agent hyporesponsiveness in the post-bundling era","volume":"2","author":"Cizman","year":"2020","journal-title":"Kidney Med"},{"key":"2024100410264912500_bib32","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/ckj\/sfad152","article-title":"Opportunities to improve the management of anemia in peritoneal dialysis patients: lessons from a national study in routine clinical practice","volume":"16","author":"Portoles","year":"2023","journal-title":"Clin Kidney J"},{"key":"2024100410264912500_bib33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000496140","article-title":"Posttransplantation anemia in kidney transplant recipients","volume":"142","author":"Gafter-Gvili","year":"2019","journal-title":"Acta Haematol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfae269\/58982345\/sfae269.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/10\/sfae269\/59591519\/sfae269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/10\/sfae269\/59591519\/sfae269.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T10:27:03Z","timestamp":1728037623000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfae269\/7746429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfae269","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,8,30]]},"article-number":"sfae269"}}